Real-World Evidence (RWE)

A deep dive into the evolving regulatory environment, the innovative approaches emerging in RWE, and the critical importance of precise data utilization

The partnership will streamline the synchronization of clinical trial and real-world data throughout the clinical research stages.

Watch our on-demand webinar featuring CVS Healthspire™ Life Sciences Solutions

Meet the team at booth #2327 at DIA to discuss your RWE needs, get a demo and see our newest human-in-the loop AI capability in action.

How Aktiia brought their continuous BP device to market by integrating vast amounts of blood pressure data with patient-reported outcomes

Watch this on-demand LinkedIn Live webinar with Castor CEO & founder, Derk Arts, featuring fellow data-driven pioneer, Jay Shah, Chief Medical Officer at Aktiia

Shedding light on the complexities and advancements in measuring PROs, drug tolerability, and quality of life in cancer trials.

As the adoption of real-world evidence (RWE) in healthcare continues to grow, and with the FDA embracing these trials more and more, researchers have come to appreciate the significance of establishing uniform approaches for evaluating and analyzing real-world data (RWD).

An avalanche of data from so many real-world sources is available today, with the promise of more data generated daily—so why not use it?